Related references
Note: Only part of the references are listed.Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Association between LAG3/CD4 Genes Variants and Risk for Multiple Sclerosis
Elena Garcia-Martin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
LAG3's Enigmatic Mechanism of Action
Colin G. Graydon et al.
FRONTIERS IN IMMUNOLOGY (2021)
Analysis of Relationships between Immune Checkpoint and Methylase Gene Polymorphisms and Outcomes after Unrelated Bone Marrow Transplantation
Hidekazu Takahashi et al.
CANCERS (2021)
Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer
Xuening Zhang et al.
Aging-US (2020)
Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis
Ila Datar et al.
CLINICAL CANCER RESEARCH (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
Nazly Santos et al.
ANNALS OF HEMATOLOGY (2018)
Transmembrane domain dependent inhibitory function of FcRIIB
Junyi Wang et al.
PROTEIN & CELL (2018)
Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
Ling-Yen Chung et al.
ONCOTARGET (2015)
Trafficking of LAG-3 to the Surface on Activated T Cells via Its Cytoplasmic Domain and Protein Kinase C Signaling
Joonbeom Bae et al.
JOURNAL OF IMMUNOLOGY (2014)
Donor CTLA-4 Genotype Influences Clinical Outcome after T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Identical Sibling Donors
Anna Bosch-Vizcaya et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
Taku Okazaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Regression modeling of competing risk using R: an in depth guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2010)
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors
Arianne Pérez-García et al.
BLOOD (2007)
Metalloproteases regulate T-cell proliferation and effector function via LAG-3
Nianyu Li et al.
EMBO JOURNAL (2007)
FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling
H Kono et al.
HUMAN MOLECULAR GENETICS (2005)
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells
L Maçon-Lemaître et al.
IMMUNOLOGY (2005)
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis
Z Zhang et al.
GENES AND IMMUNITY (2005)
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
H Ueda et al.
NATURE (2003)
A novel polymorphism in the Fc gamma receptor IIB (CD32B) transmembrane region alters receptor signaling
XL Li et al.
ARTHRITIS AND RHEUMATISM (2003)
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans
L Prokunina et al.
NATURE GENETICS (2002)
Share Paper
